Clinical Trial

Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity

Study acronym: CXCL10
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2025 (before its estimated March 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
the correlations between CXCL10 levels, CRP, and acne severity scores (e.g., Global Acne Grading System) suggest that CXCL10 could serve as a biomarker of inflammation and acne severity. Understanding the relationship between CXCL10, CRP, and acne severity may offer insights into novel therapeutic strategies targeting inflammatory pathways in acne.
Trial Details
NCT Number NCT06869109
Lead Sponsor Assiut University
Conditions Acne Vulgaris
Enrollment 88 participants
Start Date 2025-03-10
Primary Completion 2026-03-10 (estimated)
Study Completion 2026-04-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-11